Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer
EARLY DETECTION OF SECOND PRIMARY LUNG CANCERS BY SPUTUM CYTOLOGY IMMUNOSTAINING
Sponsor: Eastern Cooperative Oncology Group
This NA trial investigates Lung Cancer and is currently completed. Eastern Cooperative Oncology Group leads this study, which shows 9 recorded versions since 1995 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
-
May 2023 — Jul 2023 [monthly]
Completed NA
-
Jul 2022 — May 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Mar 2021 — Jul 2022 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Oct 1995
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eastern Cooperative Oncology Group
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
For direct contact, visit the study record on ClinicalTrials.gov .